Detalles de la búsqueda
1.
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Blood
; 139(11): 1684-1693, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614146
2.
Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia.
Am J Hematol
; 90(6): 487-92, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25691474
3.
The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells.
Int Immunol
; 23(6): 375-84, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21551245
4.
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors.
Cancer Immunol Immunother
; 59(1): 73-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19526239
5.
Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.
Clin Cancer Res
; 15(10): 3325-32, 2009 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19417016
6.
Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice.
Int J Cancer
; 124(4): 877-88, 2009 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19035460
7.
Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.
Cancer Immunol Immunother
; 58(6): 955-65, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19009294
8.
Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia.
Blood
; 119(13): 3184-5, 2012 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22461474
9.
Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.
Clin Cancer Res
; 14(21): 7088-94, 2008 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18981007
10.
Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia.
J Leukoc Biol
; 84(1): 319-25, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18426971
11.
Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Cancer Res
; 67(6): 2881-92, 2007 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17363612
12.
Clearly defined response criteria evaluating treatment of CLL patients in clinical research trials.
Blood
; 116(10): 1817; author reply 1817-8, 2010 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-20829381
13.
Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy.
Ann Hematol
; 90(6): 733-5, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20857113
14.
Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
Cancer Res
; 63(11): 2844-54, 2003 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12782590
15.
Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
Cancer Res
; 64(14): 4995-5003, 2004 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15256474
16.
Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer.
J Clin Oncol
; 22(15): 3003-15, 2004 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15210739
17.
Phase 1/2 study of ocaratuzumab, an Fc-engineered humanized anti-CD20 monoclonal antibody, in low-affinity FcγRIIIa patients with previously treated follicular lymphoma.
Leuk Lymphoma
; 56(1): 42-8, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24717109
18.
Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody.
Int J Radiat Oncol Biol Phys
; 58(3): 984-90, 2004 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14967460
19.
Anti-idiotype antibody vaccine therapy for cancer.
Expert Opin Biol Ther
; 2(8): 869-81, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12517266
20.
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study.
Leuk Lymphoma
; 55(10): 2301-4, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24369094